Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Free Cash Flow (2019 - 2025)

BioScience Health Innovations (BHIC) has disclosed Free Cash Flow for 7 consecutive years, with -$100696.0 as the latest value for Q4 2025.

  • Quarterly Free Cash Flow fell 100.17% to -$100696.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $172178.0 through Dec 2025, up 642.53% year-over-year, with the annual reading at $172178.0 for FY2025, 642.53% up from the prior year.
  • Free Cash Flow for Q4 2025 was -$100696.0 at BioScience Health Innovations, up from -$340445.0 in the prior quarter.
  • The five-year high for Free Cash Flow was $328309.0 in Q1 2025, with the low at -$340445.0 in Q3 2025.
  • Average Free Cash Flow over 5 years is -$11120.8, with a median of -$26468.5 recorded in 2022.
  • The sharpest move saw Free Cash Flow tumbled 920.93% in 2021, then soared 783.41% in 2025.
  • Over 5 years, Free Cash Flow stood at -$5901.0 in 2021, then plummeted by 372.97% to -$27910.0 in 2022, then crashed by 102.28% to -$56457.0 in 2023, then grew by 10.9% to -$50305.0 in 2024, then plummeted by 100.17% to -$100696.0 in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$100696.0, -$340445.0, and $285010.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.